[go: up one dir, main page]

DE60134881D1 - Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen - Google Patents

Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen

Info

Publication number
DE60134881D1
DE60134881D1 DE60134881T DE60134881T DE60134881D1 DE 60134881 D1 DE60134881 D1 DE 60134881D1 DE 60134881 T DE60134881 T DE 60134881T DE 60134881 T DE60134881 T DE 60134881T DE 60134881 D1 DE60134881 D1 DE 60134881D1
Authority
DE
Germany
Prior art keywords
treatment
map protein
bacteria
infections
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60134881T
Other languages
English (en)
Inventor
Joseph M Patti
Paul Domanski
Pratisksha Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inhibitex Inc
Original Assignee
Inhibitex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhibitex Inc filed Critical Inhibitex Inc
Application granted granted Critical
Publication of DE60134881D1 publication Critical patent/DE60134881D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60134881T 2000-10-20 2001-10-22 Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen Expired - Fee Related DE60134881D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24183200P 2000-10-20 2000-10-20
US27728701P 2001-03-21 2001-03-21
PCT/US2001/032550 WO2002034788A1 (en) 2000-10-20 2001-10-22 Monoclonal antibodies to the map protein and method of use in treating or preventing infections

Publications (1)

Publication Number Publication Date
DE60134881D1 true DE60134881D1 (de) 2008-08-28

Family

ID=26934627

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134881T Expired - Fee Related DE60134881D1 (de) 2000-10-20 2001-10-22 Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen

Country Status (8)

Country Link
US (1) US20020164337A1 (de)
EP (1) EP1334131B1 (de)
JP (1) JP2004512040A (de)
AT (1) ATE401349T1 (de)
AU (1) AU2002224437A1 (de)
CA (1) CA2425000A1 (de)
DE (1) DE60134881D1 (de)
WO (1) WO2002034788A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077010A2 (en) 2001-01-10 2002-10-03 The Texas A & M University System Method of preventing t-cell mediated responses by map proteins
US7463573B2 (en) 2005-06-24 2008-12-09 Nanochip, Inc. Patterned media for a high density data storage device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648240A (en) * 1994-05-24 1997-07-15 Texas A&M University MHC II analog from Staphylococcus aureus
AU6094696A (en) * 1995-06-05 1996-12-24 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefor
CA2251263A1 (en) * 1997-11-14 1999-05-14 Hajime Karasuyama Transgenic animal allergy models and methods for their use
ATE422368T1 (de) * 1998-08-31 2009-02-15 Inhibitex Inc Multikomponenten impfstoffe gegen staphylococcus aureus
WO2002077010A2 (en) * 2001-01-10 2002-10-03 The Texas A & M University System Method of preventing t-cell mediated responses by map proteins

Also Published As

Publication number Publication date
AU2002224437A1 (en) 2002-05-06
CA2425000A1 (en) 2002-05-02
EP1334131B1 (de) 2008-07-16
WO2002034788A1 (en) 2002-05-02
ATE401349T1 (de) 2008-08-15
EP1334131A4 (de) 2005-07-20
EP1334131A1 (de) 2003-08-13
JP2004512040A (ja) 2004-04-22
US20020164337A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
ATE524195T1 (de) Monoklonale antikörper gegen das clfa-protein und verfahren zur verwendung bei der behandlung bzw. pr vention von infektionen
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DE60101265D1 (de) Behandlung von augenschmerzen
TR200401314T2 (tr) Sübstitüe edilmiş oksazolidinonlar ve bunların kullanımı
ATE409181T1 (de) Proteomimetische verbindungen und verfahren
ATE309271T1 (de) Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
ATE109624T1 (de) Bakteriocine enthaltende zusammensetzungen zur verwendung als verbesserte breitspektrum- bakterizide und verfahren zur verhütung und behandlung von mikrobiellen infektionen.
ATE313328T1 (de) Verfahren zur behandlung von mittelohrinfektionen
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
ATE290548T1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
ATE310088T1 (de) Behandlung und nachweis von staphylokokkeninfektionen
DE69631381T2 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
WO2007053176A3 (en) Method of protecting against staphylococcal infection
DE60032915D1 (de) Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen
DE60134881D1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE283920T1 (de) Verfahren zur immunisierung und behandlung von h. pylori infektion
ATE303816T1 (de) Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten
WO2000063386A3 (en) Prevention, diagnosis and treatment of lyme disease
WO2005010167A3 (en) Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee